Curr Sex Health Rep (2017) 9:192–199 https://doi.org/10.1007/s11930-017-0124-3 FEMALE SEXUAL DYSFUNCTION AND DISORDERS (M CHIVERS AND C PUKALL, SECTION EDITORS) Recent Developments in Psychopharmaceutical Approaches to Treating Female Sexual Interest and Arousal Disorder Stephanie Both Published online: 19 October 2017 The Author(s) 2017, corrected publication November/2017. This article is an open access publication Abstract Definition and Prevalence of Female Sexual Interest Purpose of Review This review summarizes the recent litera- and Arousal Disorder ture and empirical studies on psychopharmacological ap- proaches to treating female sexual interest/arousal disorder Female sexual interest/arousal disorder (FSIAD) is character- (FSIAD). ized by a lack of, or significantly reduced, sexual interest and/ Recent Findings Several new drugs for FSIAD that are or arousal . It is manifested by at least three of the following intended to increase sexual responsiveness by influencing symptoms: (1) absent or reduced interest in sexual activity, (2) central excitatory and inhibitory neuromodulatory processes absent or reduced erotic thoughts or fantasies, (3) no or re- are under development. Studies on flibanserin resulted in the duced initiation of sexual activity and typical unreceptivity to first approved medication for the treatment of low sexual de- apartner’s attempts to initiate, (4) absent or reduced sexual sire
Current Sexual Health Reports – Springer Journals
Published: Oct 19, 2017
It’s your single place to instantly
discover and read the research
that matters to you.
Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.
All for just $49/month
Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly
Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.
All the latest content is available, no embargo periods.
“Whoa! It’s like Spotify but for academic articles.”@Phil_Robichaud